Evidence map›Paper›PMID 34520678›Full record

ArticleSubstance abuse2022

Collaboration in a time of crisis: Adapting a telementoring ECHO for addiction leaders during COVID-19.

Honora Englander, Alisa Patten, Jessica Gregg

Open access · greenAbstract readLetter
In one paragraph

Article in Substance abuse, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Honora EnglanderDivision of Hospital Medicine, Department of Medicine, Oregon Health & Science University, Portland, Oregon, USA.
Alisa PattenSection of Addiction Medicine, Department of Medicine, Oregon Health & Science University, Portland, Oregon, USA.
Jessica GreggSection of Addiction Medicine, Department of Medicine, Oregon Health & Science University, Portland, Oregon, USA.
Oregon Health & Science University · USOregon Health and Science University Hospital · US

Funding

Oregon Clinical and Translational Research Institute - The National COVID Cohort Collaborative (N3C)UL1TR002369 · NCATS · OREGON HEALTH & SCIENCE UNIVERSITY · PI Cynthia D Morris, Christopher G. Slatore · 2017 to 2026
$78.4M
NCATS NIH HHS UL1 TR002369
6 · The paper itself

Abstract

Substance use disorder (SUD) organizations are often siloed, with little integration across specialty addictions treatment, primary care and hospitals, harm reduction, policy, and advocacy. COVID-19 introduced a pressing need for collaboration and leadership, given a fast-changing, high-stakes environment; widespread anxiety; and lack of guidance. This research letter describes our approach to convening and supporting leaders across the US state of Oregon's SUD continuum during the pandemic. We rapidly developed and implemented a SUD COVID Response ECHO, adapting ECHO - a telementoring model - to convene leaders across 32 statewide agencies. Our experience allowed participants to lead their agencies to respond to real-time COVID-related needs, address existing barriers within SUD systems, and build relationships and community across statewide SUD leaders. This kind of collaboration - which helped bridge gaps among the diverse agencies, disciplines, and regions addressing SUDs in the state - was long overdue, and sows seeds for long-term advances in care for people with SUD.

Indexed as

Behavior, AddictiveCOVID-19Substance-Related DisordersHumansPandemicsSARS-CoV-2case-based learningcontinuing medical educationCOVID-19ECHO modelSubstance-related disorderssubstance use treatment

Identifiers

PMID34520678
PMCPMC8792166
OpenAlexW3200888909

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.